DUBLIN, Aug. 23, 2021 /PRNewswire/ -- The board of
directors of Medtronic plc (NYSE: MDT) on Friday, August 20, 2021, approved the fiscal year
2022 second quarter cash dividend of $0.63 per ordinary share, representing a 9
percent increase over the prior year. This quarterly declaration is
consistent with the dividend announcement made by the company in
May 2021. Medtronic is a constituent
of the S&P 500 Dividend Aristocrats index, having increased its
annual dividend payment for the past 44 consecutive years. The
dividend is payable on October 15,
2021, to shareholders of record at the close of business on
September 24, 2021.
About Medtronic
Medtronic plc (www.medtronic.com),
headquartered in Dublin, Ireland,
is among the world's largest medical technology, services and
solutions companies – alleviating pain, restoring health and
extending life for millions of people around the world. Medtronic
employs more than 90,000 people worldwide, serving physicians,
hospitals and patients in more than 150 countries. The company is
focused on collaborating with stakeholders around the world to take
healthcare Further, Together.
Any forward-looking statements are subject to risks and
uncertainties such as those described in Medtronic's periodic
reports on file with the Securities and Exchange Commission. Actual
results may differ materially from anticipated results.
Contacts:
|
|
|
|
Erika
Winkels
|
Ryan
Weispfenning
|
Public
Relations
|
Investor
Relations
|
+1-763-526-8478
|
+1-763-505-4626
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medtronic-announces-cash-dividend-for-second-quarter-of-fiscal-year-2022-301360043.html
SOURCE Medtronic plc